All Insights

Retail and Consumer

Consumer credit reform in the UK: where now?

A consultation response is likely later in 2023 but reform could transform consumer and small business finance markets
Retail and Consumer

Italy implements the 'Omnibus' Directive 

New information requirements, unfair commercial practices and sanctions are among the provisions that apply from April
Tech, Media and Comms

The impact of ESG factors on the future of the UK Electronic Communications Code

Environmental, social and governance issues are having a broad impact on the telecoms sector
Energy and energy transition

The Energy Transition | Energy announcements in the Budget

Welcome to our top picks of the latest energy regulatory and market developments in the UK's transition to net zero
Energy and energy transition

Smart Power | Electricity Generator Levy, site safety and repowering

Welcome to the latest edition of Smart Power, Osborne Clarke's specialist service for asset managers within the green energy sector
Employment and pensions

What effect will the Spring Budget 2023 have on UK immigration?

Policy to simplify business visitor rules may enable visitors to conduct a wider range of business activities in the UK
Tax

Spring Budget 2023 | What tax measures were announced?

A budget for growth but no cuts in tax rates
Employment and pensions

UK Employment Law Coffee Break | Spring budget 2023, new rates and limits this April, international trends and our immigration update

Welcome to our latest Coffee Break in which we look at the latest legal and practical developments impacting employers
Financial Services

Dutch legislative proposal to amend investment regime goes to consultation

Consultation on the VBI, FBI and FGR regime ends on 5 April 2023
Energy and energy transition

Smart Power | Where next for UK onshore wind and repowering?

Many wind farms are reaching the end of their lifetime and repowering these can help the UK hit its onshore
Life Sciences and Healthcare

Spring Budget 2023 | UK chancellor announces new regulatory model for medicines and medical technologies

Move raises the question of whether regulatory framework for medicines and medical devices will diverge from the EU model in